Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.
新型 Toll 受体 7/8 激动剂 3M-007 与干扰素-γ 协同增强细胞免疫反应:对皮肤 T 细胞淋巴瘤治疗的意义
期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.3109/10428194.2011.582202
Wysocka Maria, Dawany Noor, Benoit Bernice, Kossenkov Andrew V, Troxel Andrea B, Gelfand Joel M, Sell Michael Kelly, Showe Louise C, Rook Alain H